Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Subtext Launches Acquisitions Vertical; Appoints Mike Hung to Lead as Partner & Executive Vice President
-
AMSC Receives Wind Turbine Electrical Control System Order from Inox Wind
-
DZS Extends Partnership with Andorix to Transform the Infrastructure and Commercial Management Economics of Historical Landmarks
-
CPI Aerostructures Appoints Ross Johnson to Leadership Team as Vice President, Program Management
-
Integer to Showcase Latest Innovations in Neuromodulation Miniaturization During NANS 2024 Annual Meeting
-
Enphase Energy Launches New IQ8 Microinverters for High-Powered Solar Modules in Belgium
-
WiMi is Working on a New Mixed Byzantine Fault Tolerant (MBFT) Algorithm to Enhance Blockchain Fault Tolerance
-
Reviv3 Prepares for NYSE American Listing With Reverse Stock Split
-
Oncotelic Therapeutics Announces Clinical Linkage of TGFB2 and IFNGR2 in Pediatric DMG Patients
-
Titan Environmental Solutions Inc. Announces Agreement to Purchase Standard Waste Services, LLC
-
Worksport Ltd. Advances Toward COR Alpha Release: Purchases All Inventory Parts For Alpha Release Production
-
BullFrog AI Announces Issuance of Australian Patent Protecting Novel Prodrugs of Mebendazole and Their Use in Treating Cancer
-
Marathon Digital Holdings Announces the Closing of its Acquisition of Bitcoin Mining Sites
-
OROCO CLOSES NON-BROKERED PRIVATE PLACEMENT
-
AgEagle Aerial Systems Appoints Chairman Grant Begley as Interim CEO
-
WiMi is Working on a New Mixed Byzantine Fault Tolerant (MBFT) Algorithm to Enhance Blockchain Fault Tolerance
-
Dan Svejnar Joins Voltus as Senior Vice President of Growth
-
GoodBuy Gear’s 2024 Resale Report Reveals Rapid Acceleration in Baby & Kid Recommerce Among Consumers, Brands and Retailers
-
Biora Therapeutics Provides Outlook for 2024
-
Super League Announces Preliminary Record Fourth Quarter Revenue of Approximately $9.4 Million; an Increase of 32% Year-over-Year
-
ClearPoint Neuro Announces FDA Clearance for SmartFrame OR™ Stereotactic System
-
Horizon Aircraft Enters into Letter of Intent to Purchase $250M of Cavorite X7 Aircraft, with an Option for up to $500M
-
Bion’s New Patent Expands Coverage to Industrial and Municipal Waste Streams
-
New Talent, Technology and Partners: Daimler Truck and Torc enter fifth year of collaboration with eyes on the future
-
Compass Diversified Announces Partnership with The Honey Pot Company
-
Message from Renovaro Bioscience, Inc.’s CEO, The Hon. Mark Dybul, MD
-
Panbela Announces 1-for-20 Reverse Stock Split Effective January 18, 2024
-
Global Supply Chains Stabilized in 2023 with Mere 5% Annual Increase in Disruptions
-
FischTank PR Celebrates its 10-Year Anniversary
-
Kratos Receives $50 Million in Awards for Counter UAS and Air Defense Systems
-
Traction Uranium Issues Shares in Connection with Grease River Property Option Agreement
-
IEWC Partners with Redwood Logistics to Optimize Transportation Management System
-
Fluence Mosaic Intelligent Bidding Software Expands to Optimize Hybrid Renewables and Storage Assets in California Independent System Operator Wholesale Power Market
-
GTT Expands Its SASE Portfolio With Fortinet to Offer Enterprises a Robust Suite of Security Solutions Uniquely Enabled by GTT’s Global Tier 1 IP Backbone
-
Subtext Launches Acquisitions Vertical; Appoints Mike Hung to Lead as Partner & Executive Vice President
-
Genevant Sciences to Collaborate with Tome Biosciences to Develop Gene Editing Therapeutic for Rare Liver Disorder
-
Novel AI platform matches cardiologists in detecting rheumatic heart disease
-
PDS Biotech to Participate at B. Riley Securities 4th Annual Oncology Conference
-
Salarius Pharmaceuticals Issued U.S. Patent for Next-Generation Targeted Protein Degraders
-
Daxor Corporation to Exhibit at the Society for Critical Care Medicine 2024 Critical Care Congress
-
Form 8.3 - ABRDN European Logistics Income PLC
-
Jøtul AS to redeem its outstanding up to NOK 750,000,000 senior secured floating rate bonds with ISIN NO0011104069
-
Compass Pathways enters into research collaboration agreement with Hackensack Meridian Health to develop optimal clinical model for investigational COMP360 psilocybin treatment, if FDA-approved
-
60 Degrees Pharma Regains Compliance with Nasdaq Listing Requirements
-
Psyence Group Inc Subsidiary Psyence Biomedical Ltd. announces signing of definitive agreement for a convertible note in connection with planned business combination
-
Kevin Whelan Named Managing Director of Charlesbank
-
Single Use Support continues to grow, expanding its team by 40%
-
Flash News: OKX to Adjust the Minimum Order Quantities for Several Futures
-
Flash News: OKX Wallet and NFT Marketplace Revolutionize Digital Asset Trading with Aptos Digital Asset Standard Support
-
Fixing of coupon rates - Nykredit Realkredit A/S
